DCT
1:14-cv-01317
Amgen Inc v. Sanofi
General
Cause of Action--
SectorBiotech
Status
Closed (04/12/24)
Patent Owner
Operating Company (L)
PACER1:14-cv-01317
CourtD. Delaware
Judge | Period | PO Win Rate |
|---|---|---|
-- | 36% |
Plaintiff
Party
Name | Ratings |
|---|---|
L4A | |
L4A | |
L4A |
Attorney
Name | Ratings |
|---|---|
L5A | |
L4E | |
L5A | |
---- -- | |
L5D | |
L5D | |
L5E | |
L1B | |
L5D | |
L5A | |
L5B | |
L5D | |
L5E | |
L4B | |
L4C | |
L4C | |
L4C | |
L4C | |
L4E | |
L3B | |
---- -- | |
---- -- | |
L4B | |
L3B | |
L1B | |
L3C | |
---- -- | |
L2C | |
L5A | |
L5B | |
L3A | |
L3C | |
---- -- | |
---- -- | |
L2C | |
L5A | |
L5B | |
L4A | |
L4C | |
London & MeadLocal | L2D |
L2D |
Defendant
Party
Name | Ratings |
|---|---|
L5C | |
L5C | |
L5C | |
L5C | |
L5C | |
L1E |
Attorney
Name | Ratings |
|---|---|
L5A | |
L2B | |
L5A | |
---- -- | |
---- -- | |
---- -- | |
L5E | |
L4E | |
L4A | |
L5A | |
L5A | |
L5A | |
L5C | |
L5D | |
L5E | |
---- -- | |
---- -- | |
---- -- | |
L4B | |
L5A | |
L5B | |
L5C | |
L5C | |
L5D | |
L4B | |
L4C | |
L4E | |
L3-- -- | |
Ashby & GeddesLocal | L4B |
L5B | |
L5B | |
L5C | |
L4E | |
L5B | |
L5D | |
L4B | |
L4D | |
L4D | |
L4E | |
L2-- -- | |
---- -- | |
---- -- | |
L2B | |
---- -- | |
---- -- | |
L1D | |
L1D | |
L1-- -- | |
---- -- | |
Sanofi SaLocal | L1-- -- |
---- -- | |
Attorney at LawLocal | ---- -- |
---- -- |